Bradykinin, dose dependently stimulated basal and lipopolysaccharide (LPS)-induced prostaglandin E2 production, whereas exposure of astrocytes to the B1 receptor agonist decreased both basal and LPS-induced prostaglandin E2 release in a dose-dependent manner, as measured by radioimmunoassay (RIA).